Aster Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
HRCM
GS
OAM
Aster Capital Management's CDNA Position: Q2 2025 in Review
Aster Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 23,862 shares — an estimated $529K sold.
Aster Capital Management first reported a position in CDNA in Q4 2024 and held it in 2 quarters. The position peaked at $529K in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.
- Aster Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
- Aster Capital Management sold 23,862 CareDx shares in Q2 2025, an estimated $529K.
- Aster Capital Management first reported a position in CareDx in Q4 2024 and held it in 2 quarters.
- Aster Capital Management's CareDx position peaked at $529K in Q1 2025.
- 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.
Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.